The Medicines for Human Use (Clinical Trials Fees Amendments) Regulations 2004

Made: 19th April 2004

Laid before Parliament: 19th April 2004

Coming into force: 10th May 2004

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Citation, commencement and interpretation

1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of regulation 2 of the General Fees Regulations

2

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part II of the General Fees Regulations

3

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part III of the General Fees Regulations

4

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part IV of the General Fees Regulations

5

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part V of the General Fees Regulations

6

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part VI General Fees Regulations

7

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part VII of the General Fees Regulations

8

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 1 to the General Fees Regulations

9

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 2 to the General Fees Regulations

10

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 3 to the General Fees Regulations

11

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 4 to the General Fees Regulations

12

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 5 to the General Fees Regulations

13

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signed

Signed by authority of the Secretary of State for Health

Warner — Parliamentary Under Secretary of State, — Department of Health — 14th April 2004

We consent,

Nick Ainger — Jim Murphy — Two of the Lords Commissioners of Her Majesty’s Treasury — 19th April 2004

Explanatory note

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Footnotes

[^f00001]: 1972 c. 68.

[^f00002]: S.I. 1972/1811.

[^f00003]: 1973 c. 51.

[^f00004]: S.I. 1995/1116; as amended by S.I. 1996/683, 1998/574, 1999/566, 2000/592 and 3031, 2001/795, 2002/236 and 542, 2003/625 and 2321, and 2004/666.

[^f00005]: The definition of “change of ownership” was substituted by regulation 2 of S.I. 1996/683.

[^f00006]: S.I. 2004/1031.

[^f00007]: The definition of “contract laboratory” was inserted by S.I. 2004/666.

[^f00008]: S.I. 1971/972; relevant amending instruments are S.I. 1977/1053 and 1992/2846.

[^f00009]: OJ No. L121, 1.5.2001, p.34.

Editorial notes

[^key-7691ff1727742527f29f544af13e6421]: Regulations revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552), regs. 1, 48(1), Sch. 7 (with reg. 48(2))